Hypersensitivity to mosquito bites: A unique pathogenic mechanism linking Epstein-Barr virus infection, allergy and oncogenesis

Journal of Dermatological Science

Volumn 45, Issue 3, 2007, Pages 153-160

  Asada, Hideo ^a  

^a NARA MEDICAL UNIVERSITY   (Japan)

Author keywords

EB virus; Hypersensitivity to mosquito bites; LMP1; NK cells; Oncogenesis; Reactivation

Indexed keywords

ALLERGY; CARCINOGENESIS; CELL STIMULATION; CLINICAL FEATURE; EPSTEIN BARR VIRUS; FEVER; HEMOPHAGOCYTIC SYNDROME; HEPATOSPLENOMEGALY; HUMAN; HYPERSENSITIVITY; LYMPHADENOPATHY; LYMPHOCYTE PROLIFERATION; MOSQUITO; NONHUMAN; PRIORITY JOURNAL; REVIEW; SALIVARY GLAND; T LYMPHOCYTE; VIRUS INFECTION; VIRUS REACTIVATION;

ANIMALS; CULICIDAE; EPSTEIN-BARR VIRUS INFECTIONS; HUMANS; HYPERSENSITIVITY; INSECT BITES AND STINGS; VIRUS ACTIVATION;

EID: 33846783151     PISSN: 09231811     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jdermsci.2006.11.002     Document Type: Review

References (41)

1. Hidano A., Kawakami M., and Yago A. Hypersensitivity to mosquito bite and malignant histiocytosis. Jpn J Exp Med 52 (1982) 303-306
2. Schleupner C.J., and Overall J.C. Infectious mononucleosis and Epstein-Barr virus. Postgrad Med 65 (1979) 83-105
3. Henle G., Henle W., Klein G., Gunven P., Clifford P., Morrow R.H., et al. Antibodies to early Epstein-Barr virus-induced antigens in Burkitt's lymphoma. J Natl Cancer Inst 46 (1971) 861-871
4. zur Hausen H., Schulte-Holthausen H., Klein G., Henle W., Henle G., Clifford P., et al. EBV DNA in biopsies of Burkitt tumours and anaplastic carcinomas of the nasopharynx. Nature 228 (1970) 1056-1058
5. Purtilo D.T., Tatsumi E., Manolov G., Manolova Y., Harada S., Lipscomb H., et al. Epstein-Barr virus as an etiological agent in the pathogenesis of lymphoproliferative and aproliferative diseases in immune deficient patients. Int Rev Exp Pathol 27 (1985) 113-183
6. Jones J.F., Shurim S., Abramowsky C., Tubbs R.R., Sciotto C.G., Wahl R., et al. T-cell lymphomas containing Epstein-Barr viral DNA in patients with chronic Epstein-Barr virus infections. N Engl J Med 318 (1988) 733-741
7. Kawa-Ha K., Ishihara S., Ninomiya T., Yumura-Yagi K., Hara J., Murayama F., et al. CD3-negative lymphoproliferative disease of granular lymphocytes containing Epstein-Barr viral DNA. J Clin Invest 84 (1989) 51-55
8. Weiss L.M., Movahed L.A., Warnke R.A., and Sklar J. Detection of Epstein-Barr viral genomes in Reed-Sternberg cells of Hodgkin's disease. N Engl J Med 320 (1989) 502-506
9. Harabuchi Y., Yamanaka N., Kataura A., Imai S., Kinoshita T., Mizuno F., et al. Epstein-Barr virus in nasal T-cell lymphomas in patients with lethal midline granuloma. Lancet 335 (1990) 128-130
10. Su I.J., Hsieh H.C., Lin K.H., Uen W.C., Kao C.L., Chen C.J., et al. Aggressive peripheral T-cell lymphomas containing Epstein-Barr viral DNA: a clinicopathologic and molecular analysis. Blood 77 (1991) 799-808
11. Tsai T.F., Su I.J., Lu Y.C., Cheng A.L., Yeh H.P., Hsieh H.C., et al. Cutaneous angiocentric T-cell lymphoma associated with Epstein-Barr virus. J Am Acad Dermatol 26 (1992) 31-38
12. Hart D.N., Baker B.W., Inglis M.J., Nimmo J.C., Starling G.C., Deacon E., et al. Epstein-Barr viral DNA in acute large granular lymphocyte (natural killer) leukemic cells. Blood 79 (1992) 2116-2123
13. Asada H., Okada N., Tei H., Yamamura T., Hashimoto K., Kondo K., et al. Epstein-Barr virus-associated large granular lymphocyte leukemia with cutaneous infiltration. J Am Acad Dermatol 31 (1994) 251-255
14. Asada H., Okada N., Hashimoto K., Yamanishi K., Sairenji T., Hirota S., et al. Establishment and characterization of the T-cell line, EBT-8 latently infected with Epstein-Barr virus from large granular lymphocyte leukemia. Leukemia 8 (1994) 1415-1423
15. Cho K.H., Kim C.W., Lee D.Y., Sohn S.J., Kim D.W., and Chung J.H. An Epstein-Barr virus-associated lymphoproliferative lesion of the skin presenting as recurrent necrotic papulovesicles of the face. Br J Dermatol 134 (1996) 791-796
16. Iwatsuki K., Ohtsuka M., Harada H., Han G., and Kaneko F. Clinicopathologic manifestations of Epstein-Barr virus-associated cutaneous lymphoproliferative disorders. Arch Dermatol 133 (1997) 1081-1086
17. Ishihara S., Ohshima K., Tokura Y., Yabuta R., Imaishi H., Wakiguchi H., et al. Hypersensitivity to mosquito bites conceals clonal lymphoproliferation of Epstein-Barr viral DNA-positive natural killer cells. Jpn J Cancer Res 88 (1997) 82-87
18. Tokura Y., Tamura Y., Takigawa M., Koide M., Satoh T., Sakamoto T., et al. Severe hypersensitivity to mosquito bites associated with natural killer cell lymphocytosis. Arch Dermatol 126 (1990) 362-368
19. Brown A., Griffitts T.H.D., Erwin S., and Dyrenforth L.Y. Arthus' phenomenon from mosquito bites: report of a case with experimental studies. South Med J 31 (1938) 590-596
20. Ishihara S., Okada S., Wakiguchi H., Kurashige T., Morishima T., and Kawa-Ha K. Chronic active Epstein-Barr virus infection in children in Japan. Acta Paediatr 84 (1995) 1271-1275
21. Mizuki M., Ueda S., Tagawa S., Shibayama H., Nishimori Y., Shibano M., et al. Natural killer cell-derived large granular lymphocyte lymphoma of lung developed in a patient with hypersensitivity to mosquito bites and reactivated Epstein-Barr virus infection. Am J Hematol 59 (1998) 309-315
22. Ishihara S., Yabuta R., Tokura Y., Ohshima K., and Tagawa S. Hypersensitivity to mosquito bites is not an allergic disease, but an Epstein-Barr virus-associated lymphoproliferative disease. Int J Hematol 72 (2000) 223-228
23. Ohshima S., Ishii M., Asada H., Tatekawa T., Yamaguchi N., Kobayashi H., et al. A possible mechanism of NK cell-lineage granular lymphocyte proliferative disorder (NK-GLPD) in a patient with chronic active Epstein-Barr virus infection (CAEBV) and severe hypersensitivity to mosquito bites (SHMB). Intern Med 41 (2002) 651-656
24. Tsai W.C., Luo S.F., Liaw S.J., and Kuo T.T. Mosquito bite allergies terminating as hemophagocytic histiocytosis: report of a case. Taiwan Yi Xue Hui Za Zhi 88 (1989) 639-642
25. Fan P.C., and Chang H.N. Hypersensitivity to mosquito bite: a case report. Gaoxiong Yi Xue Ke Xue Za Zhi 11 (1995) 420-424
26. Ruiz-Maldonado R., Parrilla F.M., Orozco-Covarrubias M.L., Ridaura C., Tamayo Sanchez L., and Duran McKinster C. Edematous, scarring vasculitic panniculitis: a new multisystemic disease with malignant potential. J Am Acad Dermatol 32 (1995) 37-44
27. Yamamoto K., and Fukui I. Mosquito allergy. Rinsho Dermatol (Tokyo) 11 (1969) 465-472
28. Seo N., Tokura Y., Ishihara S., Takeoka Y., Tagawa S., and Takigawa M. Disordered expression of inhibitory receptors on the NK1-type natural killer (NK) leukaemic cells from patients with hypersensitivity to mosquito bites. Clin Exp Immunol 120 (2000) 413-419
29. + T-lymphocyte-induced Epstein-Barr virus reactivation in a patient with severe hypersensitivity to mosquito bites and Epstein-Barr virus-infected NK cell lymphocytosis. Arch Dermatol 139 (2003) 1601-1607
30. Tokura Y., Matsuoka H., Koga C., Asada H., Seo N., Ishihara S., et al. Enhanced T-cell response to mosquito extracts by NK cells in hypersensitivity to mosquito bites associated with EBV infection and NK cell lymphocytosis. Cancer Sci 96 (2005) 519-526
31. Fu Z., and Cannon M.J. Functional analysis of the CD4(+) T-cell response to Epstein-Barr virus: T-cell-mediated activation of resting B cells and induction of viral BZLF1 expression. J Virol 74 (2000) 6675-6679
32. Sutkowski N., Palkama T., Ciurli C., Sekaly R.P., Thorley-Lawson D.A., and Huber B.T. An Epstein-Barr virus-associated superantigen. J Exp Med 184 (1996) 971-980
33. Sutkowski N., Conrad B., Thorley-Lawson D.A., and Huber B.T. Epstein-Barr virus transactivates the human endogenous retrovirus HERV-K18 that encodes a superantigen. Immunity 15 (2001) 579-589
34. Chiang A.K., Tao Q., Srivastava G., and Ho F.C. Nasal NK- and T-cell lymphomas share the same type of Epstein-Barr virus latency as nasopharyngeal carcinoma and Hodgkin's disease. Int J Cancer 68 (1996) 285-290
35. Kaye K.M., Izumi K.M., and Kieff E. Epstein-Barr virus latent membrane protein 1 is essential for B-lymphocyte growth transformation. Proc Natl Acad Sci USA 90 (1993) 9150-9154
36. Wang D., Liebowitz D., and Kieff E. An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells. Cell 43 (1985) 831-840
37. Fahraeus R., Rymo L., Rhim J.S., and Klein G. Morphological transformation of human keratinocytes expressing the LMP gene of Epstein-Barr virus. Nature 345 (1990) 447-449
38. Wilson J.B., Weinberg W., Johnson R., Yuspa S., and Levine A.J. Expression of the BNLF-1 oncogene of Epstein-Barr virus in the skin of transgenic mice induces hyperplasia and aberrant expression of keratin 6. Cell 61 (1990) 1315-1327
39. Deacon E.M., Pallesen G., Niedobitek G., Crocker J., Brooks L., Rickinson A.B., et al. Epstein-Barr virus and Hodgkin's disease: transcriptional analysis of virus latency in the malignant cells. J Exp Med 177 (1993) 339-349
40. Cerimele F., Battle T., Lynch R., Frank D.A., Murad E., Cohen C., et al. Reactive oxygen signaling and MAPK activation distinguish Epstein-Barr virus (EBV)-positive versus EBV-negative Burkitt's lymphoma. Proc Natl Acad Sci USA 102 (2005) 175-179
41. Asada H., Saito-Katsuragi M., Niizeki H., Yoshioka A., Suguri S., Isonokami M., et al. Mosquito salivary gland extracts induce EBV-infected NK cell oncogenesis via CD4 T cells in patients with hypersensitivity to mosquito bites. J Invest Dermatol 125 (2005) 956-961